These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38415551)

  • 1. Immunohistochemical Expression of Claudin-1 and Claudin-4 in Urothelial Carcinoma of the Urinary Bladder.
    Elsayed AM; Mahmoud EI; Salem MM; Khairy RA
    Asian Pac J Cancer Prev; 2024 Feb; 25(2):637-646. PubMed ID: 38415551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of REG1A, Claudin 7 and Ki67 expressions with tumor recurrence and prognostic factors in superficial urothelial urinary bladder carcinomas.
    Yamuç E; Barışık NÖ; Şensu S; Tarhan F; Barışık CC
    Indian J Pathol Microbiol; 2022; 65(2):355-361. PubMed ID: 35435371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of claudins and their prognostic significance in noninvasive urothelial neoplasms of the human urinary bladder.
    Székely E; Törzsök P; Riesz P; Korompay A; Fintha A; Székely T; Lotz G; Nyirády P; Romics I; Tímár J; Schaff Z; Kiss A
    J Histochem Cytochem; 2011 Oct; 59(10):932-41. PubMed ID: 21832144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Claudins and ki-67: potential markers to differentiate low- and high-grade transitional cell carcinomas of the urinary bladder.
    Törzsök P; Riesz P; Kenessey I; Székely E; Somorácz A; Nyirády P; Romics I; Schaff Z; Lotz G; Kiss A
    J Histochem Cytochem; 2011 Nov; 59(11):1022-30. PubMed ID: 22043024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokeratin 20 expression is linked to stage progression and to poor prognosis in advanced (pT4) urothelial carcinoma of the bladder.
    Bruch PG; Plage H; Hofbauer S; Kornienko K; Weinberger S; Roßner F; Schallenberg S; Kluth M; Lennartz M; Blessin NC; Marx AH; Samtleben H; Fisch M; Rink M; Slojewski M; Kaczmarek K; Ecke T; Hallmann S; Koch S; Adamini N; Minner S; Simon R; Sauter G; Zecha H; Klatte T; Schlomm T; Horst D; Elezkurtaj S
    Exp Mol Pathol; 2023 Jun; 131():104860. PubMed ID: 36997051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IMP3 expression in urothelial carcinomas of the urinary bladder.
    Ozdemir NO; Türk NS; Düzcan E
    Turk Patoloji Derg; 2011 Jan; 27(1):31-7. PubMed ID: 21469424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated immunohistochemical and molecular analysis improves diagnosis of high-grade carcinoma in the urinary bladder of patients with prior radiation therapy for prostate cancer.
    Chan E; Garg K; Stohr BA
    Mod Pathol; 2020 Sep; 33(9):1802-1810. PubMed ID: 32313185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA-methylation-dependent alterations of claudin-4 expression in human bladder carcinoma.
    Boireau S; Buchert M; Samuel MS; Pannequin J; Ryan JL; Choquet A; Chapuis H; Rebillard X; Avancès C; Ernst M; Joubert D; Mottet N; Hollande F
    Carcinogenesis; 2007 Feb; 28(2):246-58. PubMed ID: 16829686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of mTOR and PTEN protein expression in schistosomal squamous cell carcinoma and urothelial carcinoma.
    Makboul R; Refaiy A; Abdelkawi IF; Hameed DA; Elderwy AA; Shalaby MM; Merseburger AS; Hussein MR
    Pathol Res Pract; 2016 May; 212(5):385-92. PubMed ID: 26916953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast activation protein (FAP) expression in CK5/6 expressed (Basal subtype) & CK20 expressed (Luminal subtype) urothelial bladder carcinoma: an immunohistochemical study.
    Hemida AS; Aiad HAES; Hassan NA; Al Sharaky DR
    J Immunoassay Immunochem; 2022 Nov; 43(6):618-633. PubMed ID: 35787739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of cell adhesion molecules in the progression of bladder urothelial carcinomas.
    Săndulescu AŞ; Stepan AE; Mărgăritescu C; Enăchescu V; Mitroi G; Simionescu CE
    Rom J Morphol Embryol; 2022; 63(1):145-151. PubMed ID: 36074678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heat-shock protein 70-2 (HSP70-2) expression in bladder urothelial carcinoma is associated with tumour progression and promotes migration and invasion.
    Garg M; Kanojia D; Seth A; Kumar R; Gupta A; Surolia A; Suri A
    Eur J Cancer; 2010 Jan; 46(1):207-15. PubMed ID: 19914824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced expression of GATA3 predicts progression in non-muscle invasive urothelial carcinoma of the urinary bladder.
    Kamel NA; Abdelzaher E; Elgebaly O; Ibrahim SA
    J Histotechnol; 2020 Mar; 43(1):21-28. PubMed ID: 31551051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tight junctions in thyroid carcinogenesis: diverse expression of claudin-1, claudin-4, claudin-7 and occludin in thyroid neoplasms.
    Tzelepi VN; Tsamandas AC; Vlotinou HD; Vagianos CE; Scopa CD
    Mod Pathol; 2008 Jan; 21(1):22-30. PubMed ID: 17962811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Cyclin D1 in Urothelial Carcinoma of Urinary Bladder and its Association with Tumour Grade.
    Nahar R; Jinnah MSA; Karim SS; Alam MM; Khatun J; Kabir E; Aktar M
    Mymensingh Med J; 2024 Apr; 33(2):461-465. PubMed ID: 38557526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced immunohistochemical PTEN staining is associated with higher progression rate and recurrence episodes in non-invasive low-grade papillary urothelial carcinoma of the bladder.
    Kulac I; Arslankoz S; Netto GJ; Ertoy Baydar D
    Virchows Arch; 2018 Jun; 472(6):969-974. PubMed ID: 29368083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection.
    Chang WC; Chang YH; Pan CC
    Am J Surg Pathol; 2012 Mar; 36(3):454-61. PubMed ID: 22261706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of polo-like kinase 1 is associated with the metastasis and recurrence in urothelial carcinoma of bladder.
    Zhang Z; Zhang G; Kong C
    Urol Oncol; 2013 Oct; 31(7):1222-30. PubMed ID: 22192978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stratification of urothelial bladder carcinoma depending on immunohistochemical expression of GATA3 and CK5/6.
    Serag Eldien MM; Abdou AG; Elghrabawy GRA; Alhanafy AM; Mahmoud SF
    J Immunoassay Immunochem; 2021 Nov; 42(6):662-678. PubMed ID: 34106817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IMP3 is a biomarker for non-muscle-invasive urothelial carcinoma of the bladder associated with an aggressive phenotype.
    Yang F; Zhou Q; Meng L; Xing N
    Medicine (Baltimore); 2019 Jul; 98(27):e16009. PubMed ID: 31277094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.